Refreshing results…
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Download from doi.orgEprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
Download from doi.orgTP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
UploadMissing publications? Search for publications with a matching author name.